- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
- Home chemotherapy
Areas of interest
Urological oncology - Renal (kidney) cancer Bladder cancer; Testicular cancer; and prostate cancer. Oncological management for these cancers including clinical supervision and planning of chemotherapy, immunotherapies, hormonal therapies and novel therapies. Also the use of Radium 223 for men with prostate cancer.
Current NHS consultant posts held
• Associate Professor of Uro-Oncology University of Oxford
• Consultant Oncologist Oxford University Hospitals NHS Foundation Trust
• Lecturer in Medicine Worcester College University of Oxford
• Co-Clinical Director NIHR LCRN Thames Valley and South Midlands
I have established and run successfully a large portfolio of clinical studies in urological cancer (some Phase I mainly phase II and III) locally, with national and international collaboration, both as CI and PI. I have published over 100 peer-reviewed papers.
Currently a member of the Testicular cancer NIHR Clinical Studies Group (CSG), previously a member of the Renal and Bladder cancer CSG’s and a member of the Bladder chemotherapy subgroup. He is also the clinical lead for the Uro-Oncology team at Oxford.
Since 2014 he has been the co-clinical director for the NIHR Thames Valley and South Midlands Clinical Research Network which supports the infrastructure and facilitates clinical research throughout the area in all healthcare settings. He also is the national lead for the testicular 100, 000 genome project which looks to develop the understanding of the genetics involved in testicular cancer.
I am also the founding trustee of a urological cancer charity (UCARE) which is a local Oxfordshire based charity supporting and funding research and raising awareness within the Thames Valley. I was also instrumental in setting up the kidney cancer support group (FROG), and helped to develop the prostate and bladder cancer support groups and set up initiatives to support men with testicular cancer.
Over 100 peer reviewed published papers
Courses offered to GPs
Multiple talks on urological cancer and research organisation
- MB BS St Thomas's Hospital 1990
- FRCP Royal College of Physicians, London 2005
- MRCP Royal College of Physicians, London 1994
- PhD University of Leeds 2000
Reference number 3487077
- Nuffield Health The Manor Hospital
- 15:30 - 20:30
- 01865 307777
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
Manor Hospital 01865 307777
Information for healthcare professionals (Bupa patients only, last 12 months)
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)
Clinical supervision and planning for delivery of chemotherapy cycle, remote or in the member's home 1-28 days - (5-50)
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 0-7 days - (5-50)
Clinical supervision and planning for delivery of chemotherapy cycle, remote or in the member's home 1-21 days - (5-50)
- Show All (6 )...